You're not alone: the Waterloo Region has a vibrant Crohn’s and colitis community, made up of people with inflammatory bowel disease, families, volunteers, and more. Throughout the year, we come together at meetings and events like the Gutsy Walk to share experiences, raise funds and heighten awareness.

There are an estimated 3,600 people with Crohn’s disease or ulcerative colitis in the Waterloo Region area. We understand the challenges you and your family may be facing – because we face them, too.
young woman sitting on couch using tablet

Canada Wide Peer Connect Event

Ready to connect with those who understand the challenges of Crohn’s disease, ulcerative colitis, and other forms of inflammatory bowel disease (IBD)?   Join our upcoming Peer Connect ...

 • 
Virtual
 • 
Family with 2 children out for a walk with mum holding a baby

Caregiver Group Peer Support Event

Ready to connect with those who understand the challenges of being a caregiver to someone with Crohn’s disease, ulcerative colitis, and other forms of inflammatory bowel disease (IBD)?   ...

 • 
Virtual
 • 
Man sitting down and looking at his cellphone

Canada Wide Peer Connect Event

Ready to connect with those who understand the challenges of Crohn’s disease, ulcerative colitis, and other forms of inflammatory bowel disease (IBD)?   Join our upcoming Peer Connect ...

 • 
Virtual
 • 
A man and a woman smiling holding coffee cups

Canada Wide Peer Connect Event

Ready to connect with those who understand the challenges of Crohn’s disease, ulcerative colitis, and other forms of inflammatory bowel disease (IBD)?   Join our upcoming Peer Connect ...

 • 
Virtual
 • 
Golfer at the Michael Thompson Memorial Golf Tournament

Michael Thompson Memorial Golf Tournament

5th Annual Michael Thompson Memorial Golf TournamentMonday, September 9, 2024 Richmond Hill Golf Club 8755 Bathurst St, Richmond Hill, ON L4C 0H4Please join us this year as we honour the legacy of ...

 • 
Richmond Hill Golf Club 8755 Bathurst St.
Richmond Hill
 • 
Speaker giving a presentation

Fertility and Pregnancy in Crohn’s and Colitis

Fertility and Pregnancy in Crohn’s and ColitisDate: September 12, 2024Time: 7:00 - 8:30 p.m. ET Did you know that Crohn’s and colitis may impact the fertility of both men and women ...

 • 
ZOOM (Virtual)
 • 
Speaker giving a presentation

Ostomy Care in Crohn’s and Colitis

Ostomy Care in Crohn’s and ColitisDate: October 8, 2024Time: 7:00 - 8:30 p.m. ET Are you, or a loved one, getting ready to live with an ostomy? Have you ever wondered how to maintain a ...

 • 
ZOOM (Virtual)
 • 
Speaker giving a presentation

Arthritis in Crohn’s and Colitis

Did you know that arthritis is a common complication for those with Crohn's disease and ulcerative colitis? Are you aware of the signs, symptoms, and treatment options for managing arthritis ...

 • 
ZOOM (Virtual)
 • 
Speaker giving a presentation

From Childhood to the Elderly: Navigating IBD Care

From Childhood to the Elderly: Navigating IBD CareDate: November 26, 2024Time: 7:00 - 8:30 p.m. ET Have you ever wondered how Crohn’s disease and ulcerative colitis impact different age ...

 • 
ZOOM (Virtual)
 • 
Speaker giving a presentation

Pain in Crohn's and Colitis

Pain in Crohn’s and Colitis Date: December 5, 2024 Time: 7:00 - 8:30 p.m. ET  Are you or a loved one struggling with pain when living with Crohn's disease or ulcerative colitis? Have ...

 • 
ZOOM (Virtuel)
 • 

Facebook

More on Facebook
 
Remember to bookmark this page.

News

The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada

The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

 8 9 10 11 12 13 14 15 16 17